Pharmacologic Treatment of Kidney Stone Disease

This article reviews the data on pharmacologic treatment of kidney stone disease, with a focus on prophylaxis against stone recurrence. One of the most effective and important therapies for stone prevention, an increase in urine volume, is not discussed because this is a dietary and not a pharmacolo...

Full description

Saved in:
Bibliographic Details
Published inUrologic clinics of North America Vol. 40; no. 1; pp. 21 - 30
Main Authors Eisner, Brian H., MD, Goldfarb, David S., MD, Pareek, Gyan, MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.2013
Subjects
Allopurinol
Allopurinol - therapeutic use
Citrate
Enzyme Inhibitors - therapeutic use
Humans
Kidney Calculi - drug therapy
Medication
Nephrolithiasis
Prevention
Thiazides
Thiazides - therapeutic use
Treatment Outcome
Urease - antagonists & inhibitors
Uric acid
Urology
Prevention
Allopurinol
Citrate
Medication
Nephrolithiasis
Uric acid
Thiazides
Online AccessGet full text

Cover

More Information
Summary:This article reviews the data on pharmacologic treatment of kidney stone disease, with a focus on prophylaxis against stone recurrence. One of the most effective and important therapies for stone prevention, an increase in urine volume, is not discussed because this is a dietary and not a pharmacologic intervention. Also reviewed are medical expulsive therapy used to improve the spontaneous passage of ureteral stones and pharmacologic treatment of symptoms associated with ureteral stents. The goal is to review the literature with a focus on the highest level of evidence (ie, randomized controlled trials).
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0094-0143
1558-318X
DOI:10.1016/j.ucl.2012.09.013